Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Administration of Proparacaine Hydrochloride 0.5% Ophthalmic Solution Prior to Canalicular Probing and Irrigation Decrease Patient Discomfort

NCT04229771 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT04229771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04229771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Administration of Proparacaine Hydrochloride 0.5% Ophthalmic Solution Prior to Canalicular Probing and Irrigation Decrease Patient Discomfort
Lead sponsor
Corewell Health East
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2020
Completion date
November 30, 2020
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dacryocystitis, dacryostenosis, epiphora